Total Payments
$3,579
2024 Payments
$136.63
Companies
27
Transactions
140
Medicare Patients
2,160
Medicare Billing
$286,229
Payment Breakdown by Category
Food & Beverage$2,245 (62.7%)
Research$1,120 (31.3%)
Education$213.57 (6.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,245 | 131 | 62.7% |
| Unspecified | $1,120 | 3 | 31.3% |
| Education | $213.57 | 6 | 6.0% |
Payments by Type
General
$2,459
137 transactions
Research
$1,120
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Retrophin, Inc. | $1,120 | 3 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $333.96 | 19 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $308.08 | 17 | $0 (2019) |
| Relypsa, Inc. | $290.08 | 16 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $273.92 | 12 | $0 (2023) |
| Vifor Pharma, Inc. | $222.23 | 14 | $0 (2023) |
| Amgen Inc. | $137.05 | 6 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $124.26 | 7 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $106.97 | 6 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $95.15 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $136.63 | 8 | Amgen Inc. ($54.33) |
| 2023 | $347.50 | 17 | Aurinia Pharma U.S., Inc. ($60.21) |
| 2022 | $259.35 | 15 | CALLIDITAS THERAPEUTICS US INC. ($56.30) |
| 2021 | $186.77 | 13 | Vifor Pharma, Inc. ($129.03) |
| 2020 | $220.77 | 12 | Relypsa, Inc. ($99.39) |
| 2019 | $482.22 | 23 | Alexion Pharmaceuticals, Inc. ($158.95) |
| 2018 | $1,514 | 26 | Retrophin, Inc. ($1,120) |
| 2017 | $431.57 | 26 | Mallinckrodt LLC ($176.07) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 08/05/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $4.15 | General |
| 04/09/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $22.77 | General |
| 03/27/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: IMMUNOLOGY | ||||||
| 03/12/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Inflammation | ||||||
| 02/07/2024 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug), BENLYSTA | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: NEPHROLOGY | ||||||
| 02/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Cardio-renal | ||||||
| 01/09/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Inflammation | ||||||
| 10/31/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: NEPHROLOGY | ||||||
| 10/25/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Genetic Disease | ||||||
| 09/19/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Rare Disease | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 06/22/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Rare Disease | ||||||
| 06/06/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: IMMUNOLOGY | ||||||
| 05/23/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/18/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Inflammation | ||||||
| 04/12/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Rare Disease | ||||||
| 03/27/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Hyperkalemia | ||||||
| 03/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Cardio-renal | ||||||
| 03/07/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Cardio-renal | ||||||
| 02/22/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/01/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Inflammation | ||||||
| 01/03/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Hyperkalemia | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| 021FSGS16010 | Retrophin, Inc. | $1,120 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 443 | 613 | $144,407 | $46,946 |
| 2022 | 12 | 461 | 1,864 | $157,712 | $50,440 |
| 2021 | 15 | 509 | 2,059 | $207,804 | $76,214 |
| 2020 | 20 | 747 | 9,091 | $334,380 | $112,630 |
Total Patients
2,160
Total Services
13,627
Medicare Billing
$286,229
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 152 | $32,680 | $13,905 | 42.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 85 | 86 | $41,052 | $11,260 | 27.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 98 | 101 | $28,684 | $10,061 | 35.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 49 | 70 | $10,220 | $4,304 | 42.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 26 | 55 | $21,450 | $3,056 | 14.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 23 | $4,738 | $2,127 | 44.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 29 | 39 | $4,017 | $1,501 | 37.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 52 | 87 | $1,566 | $730.80 | 46.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 102 | 104 | $49,152 | $15,417 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 168 | $36,120 | $15,399 | 42.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 53 | 55 | $15,620 | $5,796 | 37.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 32 | 59 | $23,010 | $3,376 | 14.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 53 | $7,738 | $2,961 | 38.3% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2022 | 12 | 1,210 | $10,890 | $2,810 | 25.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 19 | $3,964 | $1,519 | 38.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 18 | 18 | $3,798 | $1,420 | 37.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 29 | 38 | $3,914 | $1,153 | 29.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 28 | $1,456 | $278.86 | 19.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 51 | 78 | $1,404 | $231.21 | 16.5% |
| 85018 | Blood count, hemoglobin | Office | 2022 | 12 | 34 | $646.00 | $79.61 | 12.3% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 11 | 78 | $37,440 | $18,906 | 50.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 182 | $39,130 | $17,558 | 44.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 69 | 70 | $31,990 | $10,579 | 33.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 92 | 94 | $26,749 | $9,705 | 36.3% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 34 | 67 | $26,130 | $3,894 | 14.9% |
About Dr. Reginald Obi, MD
Dr. Reginald Obi, MD is a Nephrology healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841224490.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Reginald Obi, MD has received a total of $3,579 in payments from pharmaceutical and medical device companies, with $136.63 received in 2024. These payments were reported across 140 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,245).
As a Medicare-enrolled provider, Obi has provided services to 2,160 Medicare beneficiaries, totaling 13,627 services with total Medicare billing of $286,229. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Hospitalist
- Location Greenville, NC
- Active Since 07/10/2006
- Last Updated 02/23/2024
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1841224490
Products in Payments
- Veltassa (Drug) $512.31
- ACTHAR (Biological) $415.05
- SAMSCA (Drug) $271.88
- SOLIRIS (Drug) $183.98
- LUPKYNIS (Drug) $105.34
- TAVNEOS (Drug) $97.62
- Kerendia (Drug) $95.15
- ULTOMIRIS (Biological) $76.90
- Rayaldee (Drug) $66.94
- JYNARQUE (Drug) $62.08
- Auryxia (Drug) $61.98
- TARPEYO (Drug) $56.30
- BENLYSTA (Biological) $35.76
- System One (Device) $30.37
- LOKELMA (Drug) $29.77
- Parsabiv (Biological) $26.99
- XARELTO (Drug) $25.15
- AVYCAZ (Drug) $23.41
- AURYXIA (Drug) $21.67
- Envarsus XR (Drug) $19.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Greenville
William Kendrick, M.d, M.D
Nephrology — Payments: $203,057
Nephrology $203,057
Dr. Barry Gorlitsky, Md, MD
Nephrology — Payments: $175,603
Nephrology $175,603
Blake Shusterman, Md, MD
Nephrology — Payments: $66,159
Nephrology $66,159
Richard Blair, M.d, M.D
Nephrology — Payments: $13,340
Nephrology $13,340
Anthony Provenzano
Nephrology — Payments: $10,873
Nephrology $10,873
Dr. Amita Patel, M.d, M.D
Nephrology — Payments: $9,091
Nephrology $9,091